inclusion criteria: 1. adult patients 18 years - 59 years 2. confirmation of covid-19 based on the results of the real time pcr (rtpcr) examination for sars-cov-2 less than 7 days before the first day of taking the drug 3. patients with mild-moderate clinical manifestations were admitted to the hospital designated by the physician according to the operational definition of the study protocol 4. have not received covid-19 antiviral therapy 5. consciously and voluntarily participate in research

inclusion criteria: 1. adult patients 18 years - 59 years 2. confirmation of covid-19 based on the results of the real time pcr (rtpcr) examination for sars-cov-2 less than 7 days before the first day of taking the drug 3. patients with mild-moderate clinical manifestations were admitted to the hospital designated by the physician according to the operational definition of the study protocol 4. have not received covid-19 antiviral therapy 5. consciously and voluntarily participate in research

inclusion criteria: adult patients 18 years - 59 years confirmation of covid-19 based on the results of the real time pcr (rtpcr) examination for sars-cov-2 less than 7 days before the first day of taking the drug patients with mild-moderate clinical manifestations were admitted to the hospital designated by the physician according to the operational definition of the study protocol have not received covid-19 antiviral therapy consciously and voluntarily participate in research

inclusion criteria: adult patients 18 years - 59 years confirmation of covid-19 based on the results of the real time pcr (rtpcr) examination for sars-cov-2 less than 7 days before the first day of taking the drug patients with mild-moderate clinical manifestations were admitted to the hospital designated by the physician according to the operational definition of the study protocol have not received covid-19 antiviral therapy consciously and voluntarily participate in research

inclusion criteria: 1. adult patients 18 years - 59 years 2. confirmation of covid-19 based on the results of the real time pcr (rtpcr) examination for sars-cov-2 less than 7 days before the first day of taking the drug 3. patients with mild-moderate clinical manifestations were admitted to the hospital designated by the physician according to the operational definition of the study protocol 4. have not received covid-19 antiviral therapy 5. consciously and voluntarily participate in research

inclusion criteria: 1. adult patients 18 years - 59 years 2. confirmation of covid-19 based on the results of the real time pcr (rtpcr) examination for sars-cov-2 less than 7 days before the first day of taking the drug 3. patients with mild-moderate clinical manifestations were admitted to the hospital designated by the physician according to the operational definition of the study protocol 4. have not received covid-19 antiviral therapy 5. consciously and voluntarily participate in research